WA
Wasatch Advisors’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Sell |
486,936
-82,861
| -15% | -$944K | 0.03% | 184 |
|
|
2025
Q1 | $6.77M | Sell |
569,797
-29,604
| -5% | -$352K | 0.04% | 170 |
|
|
2024
Q4 | $11.3M | Sell |
599,401
-108,976
| -15% | -$2.05M | 0.06% | 154 |
|
|
2024
Q3 | $15.9M | Sell |
708,377
-149,690
| -17% | -$3.36M | 0.08% | 136 |
|
|
2024
Q2 | $17.9M | Sell |
858,067
-378,686
| -31% | -$7.9M | 0.1% | 129 |
|
|
2024
Q1 | $18.2M | Sell |
1,236,753
-1,512,992
| -55% | -$22.2M | 0.1% | 140 |
|
|
2023
Q4 | $28.4M | Sell |
2,749,745
-814,871
| -23% | -$8.41M | 0.16% | 113 |
|
|
2023
Q3 | $28M | Sell |
3,564,616
-305,159
| -8% | -$2.4M | 0.18% | 110 |
|
|
2023
Q2 | $38.7M | Buy |
3,869,775
+695,773
| +22% | +$6.95M | 0.23% | 87 |
|
|
2023
Q1 | $28.2M | Buy |
3,174,002
+635,370
| +25% | +$5.64M | 0.18% | 107 |
|
|
2022
Q4 | $27.9M | Sell |
2,538,632
-118,805
| -4% | -$1.3M | 0.19% | 104 |
|
|
2022
Q3 | $34.6M | Buy |
2,657,437
+394,374
| +17% | +$5.14M | 0.24% | 96 |
|
|
2022
Q2 | $28.7M | Buy |
2,263,063
+716,374
| +46% | +$9.08M | 0.18% | 110 |
|
|
2022
Q1 | $21.7M | Buy |
1,546,689
+343,100
| +29% | +$4.81M | 0.11% | 150 |
|
|
2021
Q4 | $34.8M | Buy |
1,203,589
+31,932
| +3% | +$924K | 0.14% | 128 |
|
|
2021
Q3 | $35.1M | Sell |
1,171,657
-22,958
| -2% | -$688K | 0.14% | 133 |
|
|
2021
Q2 | $31.7M | Buy |
1,194,615
+158,914
| +15% | +$4.22M | 0.13% | 146 |
|
|
2021
Q1 | $32.2M | Buy |
+1,035,701
| New | +$32.2M | 0.14% | 127 |
|